(Health-NewsWire.Net, May 05, 2022 ) Cell Culture Media Market 2022
The global Cell Culture Media Market is expected to witness a CAGR of 7.1% and reach US$ 5.6 Bn by the year 2031. With how healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be the healthcare industry’s situation in the upcoming period.
According to a recent study by Persistence Market Research, the global cell culture media market is anticipated to witness high growth over the coming years. The market is predicted to grow from US$ 2.6 Bn in 2020 to over US$ 5.6 Bn by 2031. This reveals a CAGR of around 7.1% for the forecast period (2021-2031).
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31338
Demand for cell culture media is increasing with rising production of biopharmaceuticals. Biopharmaceutical drugs are structurally similar to human compounds. This similarity in structure gives biopharmaceuticals the ability to cure diseases rather than only treat the symptoms. Also, biopharmaceuticals have fewer side effects because of their specificity, unlike conventional drugs that affect multiple systems. Biopharma is helping doctors in treating various diseases such as diabetes and cancer, because it allows clinicians to give specialized treatment to the specific medical problems of each patient.
With increasing demand for regenerative medicines, sale of cell culture media also increases. It is because regenerative medicine is that branch of medicine that develops methods to regrow, heal or replace injured or unhealthy cells, organs, and tissues.
Thermo Fisher Scientific Inc.
STEMCELL Technologies Inc
MP Biomedicals, LLC
Becton, Dickinson and Company
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/31338
Key Takeaways from Market Study
By product, serum-free media holds a high share of 51.4% in 2021. Serum-free media is mainly used due to minimum risk of contamination.
By application, cancer research of cell culture media accounts for 43.7% market share.
By end user, biopharmaceutical companies account for 83.3% market share, indicating rising demand for stem cells and tissue engineering.
By region, North America holds the largest share of 32.6% of the global cell culture media market.
“Increasing production of antibodies for treatment of diseases and rising prevalence of cancer are expected to drive demand of cell culture media over the decade,” says a Persistence Market Research analyst.
Who is Winning?
Some of the chief manufacturers of cell culture media are focusing on product launches, collaborations, and acquisitions for global expansion objectives, thereby enhancing their market presence.
In March 2021, PromoCell launched the improved 3rd generation melanocyte cell culture portfolio.
In May 2018, MP Biomedicals announced that it gained approval from the General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China (AQSIQ), to export bovine blood products to China.
In 2019, PAN Biotech announced its plan of expansion for export of fetal bovine serum globally.
Key market players covered in this research include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Lonza, Corning Incorporated, Irvine Scientific, STEMCELL Technologies Inc., and PAN Biotech.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/31338
Want More Valuable Insights?
Persistence Market Research brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cell culture media Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights into the cell culture media market. The market is segmented into five parts based on product (serum containing media, serum-free media, protein free media, and chemically defined media) based on application (cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, stem cell technologies, and others) based on the end user (biopharmaceutical companies, clinical research organizations, and academic research centers), and across seven major regions.
Best Research Reports for You-
Lateral Flow Assays Market -
The global lateral flow assay market was valued at US$ 3.7 Bn in 2020, and is projected to register a CAGR of 5.1% through 2031.
MRI Systems Market -
The global MRI systems market was valued at US$ 8 Bn in 2020, and is expected to register a CAGR of 6.5% over the forecast period (2021-2031).
Antibodies Contract Manufacturing Market -
The global antibodies contract manufacturing market was valued at US$ 3.87 Bn in 2020, and is expected to register a high CAGR of 13% during the forecast period (2021-2031).
Dialysis Machines Market -
Demand for hemodialysis devices is expected to increase 3% to around 65,181,120 units by 2031, while that for peritoneal devices is slated to progress at 3.3% to around 1,39,22,871 units by the same year.
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Persistence Market Research